Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin‐proteasome system

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The FEBS Journal

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/febs.14193PMID 28786561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubiquitin System

  2018cited by this paper
• The human papillomavirus E7 oncoprotein as a regulator of transcription.

  2017cited by this paper
• The biology of beta human papillomaviruses.

  2017cited by this paper
• Structural investigation on the intrinsically disordered N-terminal region of HPV16 E7 protein

  2016cited by this paper
• High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation

  2016cited by this paper
• DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway

  2015cited by this paper
• Abstract 1229: E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis

  2015cited by this paper
• Ubiquitination in the antiviral immune response.

  2015cited by this paper
• Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53

  2015cited by this paper
• Quantifying domain-ligand affinities and specificities by high-throughput holdup assay

  2015cited by this paper
• The Ubiquitin-Specific Protease USP15 Promotes RIG-I–Mediated Antiviral Signaling by Deubiquitylating TRIM25

  2014cited by this paper
• USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses

  2014cited by this paper
• PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6

  2014cited by this paper
• Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

  2014cited by this paper
• High‐risk HPV types and head and neck cancer

  2014cited by this paper
• USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination

  2014cited by this paper
• The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response

  2013cited by this paper
• USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110

  2013cited by this paper
• Exploration of Binary Virus–Host Interactions Using an Infectious Protein Complementation Assay*

  2013cited by this paper
• Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins

  2013cited by this paper
• UUCD: a family-based database of ubiquitin and ubiquitin-like conjugation

  2012cited by this paper
• Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses

  2012cited by this paper
• Large Scale Genotype Comparison of Human Papillomavirus E2-Host Interaction Networks Provides New Insights for E2 Molecular Functions

  2012cited by this paper
• Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.

  2012cited by this paper
• TRIM32 Protein Modulates Type I Interferon Induction and Cellular Antiviral Response by Targeting MITA/STING Protein for K63-linked Ubiquitination*

  2012cited by this paper
• Benchmarking a luciferase complementation assay for detecting protein complexes

  2011cited by this paper
• Viral Takeover of the Host Ubiquitin System

  2011cited by this paper
• JTV1 co‐activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress

  2011cited by this paper
• Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.

  2010cited by this paper
• TRAF5 Is a Downstream Target of MAVS in Antiviral Innate Immune Signaling

  2010cited by this paper
• Defining the human deubiquitinating enzyme interaction landscape.

  2009cited by this paper
• Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin.

  2009cited by this paper
• Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement.

  2009cited by this paper
• The Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability

  2009cited by this paper
• Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-β Induction during the Early Phase of Viral Infection*

  2009cited by this paper
• Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and Signaling

  2008cited by this paper
• An experimentally derived confidence score for binary protein-protein interactions

  2008cited by this paper
• USP11 Stabilizes HPV-16E7 and Further Modulates the E7 Biological Activity*

  2008cited by this paper
• Neuralized-like 1 (Neurl1) Targeted to the Plasma Membrane by N-Myristoylation Regulates the Notch Ligand Jagged1*

  2008cited by this paper
• Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor

  2007cited by this paper
• DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase.

  2007cited by this paper
• TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity

  2007cited by this paper
• Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7

  2006cited by this paper
• Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell‐cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells

  2006cited by this paper
• Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600.

  2005cited by this paper
• Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

  2004cited by this paper
• Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.

  2004cited by this paper
• Papillomaviruses and cancer: from basic studies to clinical application

  2002cited by this paper
• Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3

  2002cited by this paper
• Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells

  2001cited by this paper
• Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase

  2000cited by this paper
• Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

  2000cited by this paper
• Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue

  2000cited by this paper
• Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation

  1999cited by this paper
• Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7

  1998cited by this paper
• Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.

  1996cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

  1989cited by this paper

• Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis

  2025cites this paper
• The emerging role of USP29 in cancer and other diseases

  2024cites this paper
• The performance of JAM3/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection

  2024cites this paper
• Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4

  2024cites this paper
• Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1α Axis

  2024influential citation
• The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer

  2024cites this paper
• Exploring type I interferon pathway: virulent vs. attenuated strain of African swine fever virus revealing a novel function carried by MGF505-4R

  2024cites this paper
• Too many cooks in the kitchen: HPV driven carcinogenesis – The result of collaboration or competition?

  2024cites this paper
• Influenza A Virus NS1 protein and the human ubiquitin proteasome

  2023cites this paper
• High-grade cervical lesions diagnosed by JAM3/PAX1 methylation in high-risk human papillomavirus-infected patients.

  2023cites this paper
• The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer

  2023cites this paper
• Structure of high-risk papillomavirus type 31 E6 oncogenic protein and characterization of E6/E6AP/p53 complex formation

  2023cites this paper
• The ubiquitin specific protease 7 stabilizes HPV16E7 to promote HPV-mediated carcinogenesis

  2023cites this paper
• Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair

  2023cites this paper
• Characterization of anti-GASP motif antibodies that inhibit the interaction between GPRASP1 and G protein-coupled receptors.

  2023cites this paper
• HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources

  2022cites this paper
• Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells

  2022cites this paper
• Association strength of E6 to E6AP/p53 complex correlates with HPV‐mediated oncogenesis risk

  2022cites this paper
• Regulation of HPV E7 Stability by E6-Associated Protein (E6AP)

  2022cites this paper
• USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets

  2022cites this paper
• CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells

  2022cites this paper
• High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression

  2022cites this paper
• Multifaceted roles of TAX1BP1 in autophagy

  2022cites this paper
• Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle

  2021cites this paper
• Molecular Analysis of the Interaction between Human PTPN21 and the Oncoprotein E7 from Human Papillomavirus Genotype 18

  2021cites this paper
• Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms

  2021cites this paper
• The VP3 Protein of Bluetongue Virus Associates with the MAVS Complex and Interferes with the RIG-I-Signaling Pathway

  2021influential citation
• SearcHPV: a novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer

  2021cites this paper
• Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer

  2021cites this paper
• TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense

  2021cites this paper
• HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins

  2021cites this paper
• Human papillomavirus E6 and E7: What remains?

  2021cites this paper
• Human papillomavirus-mediated carcinogenesis and tumor progression

  2021cites this paper
• PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6

  2021cites this paper
• The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib

  2021cites this paper
• Orthogonal ubiquitin transfer reveals human papillomavirus E6 downregulates nuclear transport to disarm interferon‐γ dependent apoptosis of cervical cancer cells

  2021cites this paper
• The Anaphase Promoting Complex/ cyclosome co-activator, Cdh1, is a novel target of human Papillomavirus 16 E7 oncoprotein in cervical oncogenesis

  2021cites this paper
• The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells

  2021cites this paper
• HPV-induced cancers: preclinical therapeutic advancements

  2021cites this paper
• Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation

  2020cites this paper
• Recognition of high-risk HPV E6 oncoproteins by 14-3-3 proteins studied by 1 interactomics and crystallography 2

  2020cites this paper
• The Human PDZome 2.0: Characterization of a New Resource to Test for PDZ Interactions by Yeast Two-Hybrid

  2020cites this paper
• Recognition of high-risk HPV E6 oncoproteins by 14-3-3 proteins studied by interactomics and crystallography

  2020cites this paper
• Inferring Virus-Host relationship between HPV and its host Homo sapiens using protein interaction network

  2020cites this paper
• HPV E6 and E7 oncoproteins cooperatively alter the expression of Disc Large 1 polarity protein in epithelial cells

  2020cites this paper
• Targeting the E3 Ubiquitin Ligases DCAF15 and Cereblon for Cancer Therapy.

  2020cites this paper
• TNFAIP1 Is Upregulated in APP/PS1 Mice and Promotes Apoptosis in SH-SY5Y Cells by Binding to RhoB

  2020cites this paper
• HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?

  2020influential citation
• Backbone 1H, 13C, and 15N resonance assignments of the PRY-SPRY domain of RNF135

  2019cites this paper
• The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells

  2019cites this paper
• The Role of HPV E7 in Maintenance of Cell Transformation

  2019cites this paper
• Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex

  2019cites this paper
• HIV-1 Impairment via UBE3A and HIV-1 Nef Interactions Utilizing the Ubiquitin Proteasome System

  2019cites this paper
• MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral Envelopment

  2019cites this paper
• Degradation of proteins by PROTACs and other strategies

  2019cites this paper
• The structural basis of Indisulam-mediated recruitment of RBM39 to the DCAF15-DDB1-DDA1 E3 ligase complex

  2019cites this paper
• Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus

  2019cites this paper
• USP21 modulates Goosecoid function through deubiquitination

  2019cites this paper
• Structural Insights in Multifunctional Papillomavirus Oncoproteins

  2018cites this paper
• High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis

  2018cites this paper
• The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis

  2018cites this paper
• Viral oncoproteins and ubiquitination: accessing a cellular toolbox for modifying protein function

  2017cites this paper
• Comparative Profiling of Ubiquitin Proteasome System Interplay with Influenza A Virus PB2 Polymerase Protein Recapitulating Virus Evolution in Humans

  2017cites this paper